U.S. Cath Labs Market Size To Reach $25.8 Billion By 2033

U.S. Cath Labs Market Growth & Trends

The U.S. cath labs market size is estimated to reach USD 25.8 billion by 2033, registering a CAGR of 5.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. The high incidence of heart disease in the U.S., the improving spending capacity of the residents, the growing number of therapeutic surgeries, and technological advancements are fueling market growth. In addition, the increasing preference for minimally invasive surgeries is expected to offer growth opportunities for the market.

The volume of heart disease diagnostics and surgeries performed is increasing in the U.S. As per the American Heart Association, more than 1 million catheterization surgeries are performed every year. The northeastern and southeastern regions in the U.S. have the highest hospitalization rates for heart disease patients. Michigan, Ohio, West Virginia, Alabama, Georgia, North Carolina, and Kentucky are the states having the highest hospitalization rates for heart disease as per the CDC. This indicates the high requirement for heart disease treatment and the huge accessibility to service in the U.S.

The COVID-19 pandemic resulted in a decline in the number of cardiac procedures as COVID-19 care was the primary focus wherein several cath labs were converted into intensive care units for COVID-19 patients temporarily. The cath labs also witnessed a shortage of medical devices due to disruption in the supply chain during the initial phase of the pandemic. Automated external defibrillators having application in cardiac diagnostic procedures were the equipment having the least supply during the pandemic. The later phase of the pandemic witnessed increased demand for services owing to the rise in heart disease resulting from inactivity during the pandemic.

 Request a free sample copy or view report summary: U.S. Cath Labs Market Report

U.S. Cath Labs Market Report Highlights

• Based on component, the services segment accounting for the largest revenue share of 45.85% in 2025, attributed to the rising prevalence of cardiovascular diseases in the U.S.

• The equipment segment is expected to grow at the fastest CAGR over the forecast period, attributed to the increasing need for diagnostic and therapeutic surgical procedures.

• Based on facility type, the hospital-based labs segment held the largest revenue share in 2025, attributed to the increasing number of corporate hospital-based cath labs, favorable reimbursement, and the accessibility of top-quality care and equipment in hospital-based settings.

U.S. Cath Labs Market Segmentation

Grand View Research has segmented the U.S. cath labs market report based on component, facility type, and region:

U.S. Cath Labs Component Outlook (Revenue, USD Million, 2021 - 2033)

• Services

  • Therapeutic

    • Angioplasty

    • Stent placement

    • Rotational atherectomy

    • Thrombectomy

    • Cardioversion

    • Transcatheter Aortic Valve Replacement (TAVR)

    • Others

  • Diagnostic

    • Angiography

    • Coronary intravascular ultrasound

    • Cardiac catheterization

    • ECG/EKG

    • Fractional Flow Reserve (FFR)

    • Others

• Equipment

  • Imaging Equipment

    • Angiography machines

    • X-ray machines

    • IVUS

  • Monitors

  • Procedure Room Equipment

    • X-ray table

    • Heart monitoring equipment

    • Display screens

  • Control Room Equipment

    • Viewing monitor

    • Hemodynamic monitoring system

  • Other Equipment

    • Infusion pumps

    • Anesthetic and respiratory equipment

    • Crash cart

• Medical Devices

  • Stents

  • Sheaths

  • Guidewires

  • Pacemakers

  • Defibrillator

  • CPR device

  • Others

U.S. Cath Labs Facility Type Outlook (Revenue, USD Million, 2021 - 2033)

• Independent Labs

• Hospital-Based Labs

List of Key Players in U.S. Cath Labs Market

Manufacturers

• Boston Scientific Corporation

• GE Healthcare

• Koninklijke Philips N.V.

• Siemens Healthineers

• Abbott Laboratories

• Stryker

• Cordis

• AngioDynamics

• Medtronic

• Shimadzu Corporation

• Johnson & Johnson

• B. Braun Melsungen AG

• Cardinal Health, Inc.

Service Providers

• Cleveland Clinic

• Cedars-Sinai

• Mayo Clinic

• NewYork-Presbyterian Hospital

• Northwestern Medicine

• Stanford Health Care

• Houston Methodist